ACER   $0.9  3.41% Market Closed

Acer Therapeutics Inc
Total Cash 1.55M
totalCashPerShare 0.063
EBITDA -19.73M
Total Debt 32.27M
quickRatio 0.036
currentRatio 0.155
Total Revenue
debtToEquity
Revenue/Share
ROA -0.65272003
ROE
grossProfits
freeCashflow -19.90M
operatingCashflow -31.91M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 46.87M
forwardPE 2.7504168
floatShares 18.37M
sharesOutstanding 24.46M
sharesShort 493.55K
sharesShortPriorMonth 898.08K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.14%
heldPercentInstitutions 0.30%
Short Ratio help_outline 2.87%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -1.359
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -38.76M
trailingEps -1.93%
forwardEps 0.24%
enterpriseToEbitda -2.38
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.09 4Q 2023
institutionsCount 34
lastUpdated Jan. 20, 2024, 11:13 p.m.